Perrigo Company (NYSE:PRGO)‘s stock had its “hold” rating reaffirmed by equities research analysts at Jefferies Group LLC in a research report issued on Friday. They presently have a $71.00 price target on the stock, up from their previous price target of $69.00. Jefferies Group LLC’s price objective points to a potential downside of 9.54% from the company’s current price.

Other research analysts have also issued research reports about the stock. Deutsche Bank AG decreased their price target on shares of Perrigo from $87.00 to $86.00 and set a “buy” rating on the stock in a research report on Wednesday, April 19th. Canaccord Genuity set a $86.00 price target on shares of Perrigo and gave the stock a “buy” rating in a research report on Monday, May 22nd. Cantor Fitzgerald set a $85.00 price target on shares of Perrigo and gave the stock a “buy” rating in a research report on Monday, July 24th. Royal Bank Of Canada restated a “hold” rating and issued a $66.00 price target on shares of Perrigo in a research report on Wednesday, May 24th. Finally, BidaskClub upgraded shares of Perrigo from a “sell” rating to a “hold” rating in a research report on Tuesday, June 20th. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and seven have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $85.93.

Shares of Perrigo (NYSE PRGO) traded up 2.15% during midday trading on Friday, reaching $78.49. The company’s stock had a trading volume of 3,098,001 shares. The stock’s 50 day moving average is $73.48 and its 200 day moving average is $73.02. Perrigo has a 12 month low of $63.68 and a 12 month high of $99.14. The stock’s market capitalization is $11.26 billion.

Perrigo (NYSE:PRGO) last posted its quarterly earnings results on Thursday, August 10th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.94 by $0.28. The firm had revenue of $1.24 billion for the quarter, compared to analyst estimates of $1.18 billion. Perrigo had a negative net margin of 43.81% and a positive return on equity of 11.79%. The firm’s quarterly revenue was down 7.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.93 earnings per share. On average, analysts forecast that Perrigo will post $4.32 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Perrigo Company (PRGO) Receives “Hold” Rating from Jefferies Group LLC” was originally published by Daily Political and is owned by of Daily Political. If you are viewing this story on another domain, it was stolen and reposted in violation of US & international copyright and trademark law. The legal version of this story can be read at https://www.dailypolitical.com/2017/08/11/perrigo-company-prgo-receives-hold-rating-from-jefferies-group-llc.html.

Several institutional investors have recently bought and sold shares of PRGO. Korea Investment CORP boosted its position in Perrigo by 142.0% in the second quarter. Korea Investment CORP now owns 1,331 shares of the company’s stock valued at $101,000 after buying an additional 781 shares in the last quarter. Commonwealth Bank of Australia boosted its position in Perrigo by 13.8% in the second quarter. Commonwealth Bank of Australia now owns 1,455 shares of the company’s stock valued at $108,000 after buying an additional 176 shares in the last quarter. Johnson Financial Group Inc. boosted its position in Perrigo by 15.6% in the first quarter. Johnson Financial Group Inc. now owns 1,775 shares of the company’s stock valued at $118,000 after buying an additional 240 shares in the last quarter. Global X Management Co. LLC boosted its position in Perrigo by 56.4% in the first quarter. Global X Management Co. LLC now owns 2,370 shares of the company’s stock valued at $157,000 after buying an additional 855 shares in the last quarter. Finally, Bessemer Group Inc. boosted its position in Perrigo by 1,046.2% in the second quarter. Bessemer Group Inc. now owns 2,235 shares of the company’s stock valued at $169,000 after buying an additional 2,040 shares in the last quarter. Institutional investors and hedge funds own 76.38% of the company’s stock.

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.

Analyst Recommendations for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Company and related companies with MarketBeat.com's FREE daily email newsletter.